Feasibility and acceptance of a nonpharmacological cognitive remediation intervention for patients with Parkinson disease

Journal of Geriatric Psychiatry and Neurology

Volumn 24, Issue 2, 2011, Pages 91-97

  Mohlman, Jan ^a   Chazin, Daniel ^a   Georgescu, Bianca ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

cognitive deficits; cognitive rehabilitation; cognitive remediation; executive skills; feasibility; nonmotoric symptoms; Parkinson disease

Indexed keywords

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITIVE THERAPY; EXERCISE; FATIGUE; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; REWARD; TASK PERFORMANCE;

AGED; COGNITION DISORDERS; COGNITIVE THERAPY; EXECUTIVE FUNCTION; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX;

EID: 79955739443     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988711402350     Document Type: Article

References (57)

1. Norman DA, Shallice T. Attention to action: Willed and automatic control of behavior. In: Davidson RJ, Schwarts GE, Shapiro D, eds. Consciousness and self-regulation: Advances in research and therapy. New York, NY: Plenum Press; 1986: 1-18.
2. Fuster JM The prefrontal cortex. 3rd ed. Philadelphia, PA: Lippincott-Raven ; 1997.
3. Ehrt U., Aarsland D. Psychiatric aspects of Parkinson's disease. Curr Opin Psychiatry. 2005 ; 18 (3). 335-341. (Pubitemid 40586118)
4. Muslimovic D., Post B., Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology. 2005 ; 65 (8). 1239-1245. (Pubitemid 41508217)
5. Leroi I., Collins D., Marsh L. Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review. J Neurol Sci. 2006 ; 248 (1). 104-114. (Pubitemid 44647299)
6. Thommessen B., Aarsland D., Braekhus A., Oksengaard AR, Engedal K., Laake K. The psychosocial burden on spouses of the elderly with stroke, dementia and Parkinson's disease. Int J Geriatr Psychiatry. 2002 ; 17 (1). 78-84. (Pubitemid 34121101)
7. Fenelon G., Mahieux F., Huon R., Ziegler M. Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors. Brain. 2000 ; 123 (4). 733-745. (Pubitemid 30162723)
8. Schrag A., Jahanshahi NQ What contributes to quality of life in patients with Parkinson's disease ? J Neurol Neurosurg Psychiatry. 2004 ; 69 (3). 308-312.
9. Zgaljardic DJ, Borod JC, Foldi NS, et al. An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. J Clin Exp Neuropsychol. 2006 ; 28 (7). 1127-1144.
10. Bassett SS Cognitive impairment in Parkinson's disease. Prim psychiatry. 2005 ; 12 (7). 50-55. (Pubitemid 41023307)
11. Klepac N., Hajnsek S., Trkulja V. Cognitive performance in nondemented nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms. J Geriatr Psychiatry Neurol. 2010 ; 23 (1). 15-26.
12. Kummer A., Hars•nyi E, Dias F., Cardoso F., Caramelli P., Teixeira AL Depression impairs executive functioning in Parkinson disease patients with low educational level. Cogn Behav Neurol. 2009 ; 22 (3). 167-172.
13. Ryder KA, Gontkovsky ST, McSwan KL, Scott JG, Bharucha KJ, Beatty WW Cognitive function in Parkinson's Disease: Association with anxiety but not depression. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2002 ; 9 (2). 77-84.
14. Alexopoulos GS, Kiosses DN, Klimstra S., Kalayam B. Clinical presentation of the "depression-executive dysfunction syndrome" of late life. Am J Geriatr Psychiatry. 2002 ; 10 (1). 98-106. (Pubitemid 34052908)
15. Mohlman J., Gorman JM The role of executive functioning in CBT: a pilot study with anxious older adults. Behav Res Ther. 2005 ; 43 (4). 447-465. (Pubitemid 40208588)
16. Potagas C., Papageorgiou S. Phenomenology and management of cognitive and behavioral disorders in Parkinson's disease. Rise and logic of dementia in Parkinson's disease. Annals Gen Psychiat. 2006 ; 5 (12). 1-9.
17. Arciniegas DB, Beresford TP Neuropsychiatry: An introductory approach. Cambridge, UK: Cambridge University Press ; 2001.
18. Linazasoro G., Lasa A., Van Blercom N. Efficacy and safety of donepezil in the treatment of executive dysfunction in Parkinson disease: a pilot study. Clin Neuropharmacol. 2005 ; 28 (4). 176-178. (Pubitemid 41134244)
19. Rektorova I., Rektor I., Bares M., et al. Cognitive performance in people with Parkinson's disease and mild or moderate depression: effects of dopamine agonists in an add-on to L-dopa therapy. Eur J Neurology. 2005 ; 12 (1). 9-15.
20. Grace J., Amick MM, Friedman JH A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease. J Neurol Neurosurg Psychiatry. 2008 ; 80 (1). 18-23.
21. Leroi I., Brandt J., Reich SG, Lyketsos CG, Grill S., Thompson R., Marsh L. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry. 2002 ; 19 (1). 1-8.
22. Witt K., Pulkowski U., Herzog J., et al. Deep brain stimulation of the subthalamic nucleus improves cognitive flexibility but impairs response inhibition in Parkinson disease. Arch Neurol. 2004 ; 61 (5). 697-700. (Pubitemid 38637686)
23. Zahodne LB, Okun MS, Foote KD, et al. Cognitive declines one year after unilateral deep brain stimulation surgery in parkinson's disease: a controlled study using reliable change. Clin Neuropsychol. 2009 ; 23 (3). 385-405.
24. Ball K., Berch DB, Helmers KF, et al. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA. 2002 ; 288 (18). 2271-2281. (Pubitemid 35291757)
25. Butti G., Buzzelli S., Fiori M., Giaquinto S. Observations on mentally impaired elderly patients treated with THINKable, a computerized cognitive remediation. Arch Gerontol Geriatr. 1998 ; 26 (suppl 1). 49-56.
26. Gordon WA, Hibbard MR Critical issues in cognitive remediation. Neuropsychology. 1992 ; 6 (4). 361-370.
27. Raskin SA Cognitive remediation of mild traumatic brain injury in an older age group. In: Raskin SA, Mateer CA, eds. Neuro-psychological management of mild traumatic brain injury. New York, NY: Oxford University Press; 2000: 254-268.
28. Sinforiani E., Banchieri L., Zucchella C., Pacchetti C., Sandrini G. Cognitive rehabilitation in Parkinson's disease. Arch Gerontol Geriatr. 2004 ; 9 (suppl): 387-391. (Pubitemid 38822889)
29. Sammer G., Reuter I., Hullman K., Kaps M., Vaitl D. Training of executive functions in Parkinson's disease. J Neurolog Sci. 2006 ; 248 (1). 115-119. (Pubitemid 44647304)
30. Sohlberg MM, Johnson L., Paule L., Raskin SA, Mateer CA APT-II: A program to address attentional deficits for persons with mild cognitive dysfunction. Wake Forest, NC: Lash & Associates; 2001.
31. Silverstein SM, Hatashita-Wong M., Solar BA, et al. Effectiveness of a two-phase cognitive rehabilitation intervention for severely impaired schizophrenia patients. Psychol Med. 2005 ; 35 (6). 829-837. (Pubitemid 40873383)
32. Sohlberg MM, McLaughlin KA, Pavese A., Heidrich A., Posner MI Evaluation of attention process training and brain injury education in persons with acquired brain injury. J Clin Exp Neuropsychol. 2000 ; 22 (5). 656-676.
33. Mohlman J. More power to the executive? CBT plus executive training for late life generalized anxiety disorder. Cogn Behav Pract. 2008 ; 15: 306-316.
34. Berridge KC, Robinson TE What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev. 1998 ; 28 (3). 309-369. (Pubitemid 29012677)
35. Mattox ST, Valle-Inclan F., Hackley SA Psychophysiological evidence for impaired reward anticipation in Parkinson's disease. Clin Neurophysiol. 2006 ; 117 (10). 2144-2153. (Pubitemid 44333263)
36. Czernecki V., Pillon B., Houeto JL, Pochon JB, Levy R., Dubois B. Motivation, reward, and Parkinson's Disease: Influence of dopatherapy. Neuropsychologia. 2002 ; 40 (13). 2257-2267. (Pubitemid 35303365)
37. Hart RP, Wade JB, Calabrese VP, Colenda CC Vigilance performance in Parkinson's disease and depression. J Clin Exp Neuropsychol. 1998 ; 20 (1). 111-117. (Pubitemid 28318064)
38. Pallier G. Gender differences in the self-assessment of accuracy on cognitive tasks. Sex Roles. 2003 ; 48 (5-6). 265-276.
39. Folstein MF, Folstein SE, McHugh PR " Mini-mental state:" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 ; 12 (3). 189-198.
40. Meyer T., Miller M., Metzger R., Borkovec TD Development and validity of the Penn State Worry Scale. Behav Res Ther. 1990 ; 28 (6). 487-495.
41. Beck AT, Steer RA Manual for the Beck Anxiety Inventory. San Antonio, TX: Psychological Corporation ; 1990.
42. Spielberger C., Gorsuch R., Lushene R. State-Trait Anxiety Inventory: Test Manual. Palo Alto, CA: Consulting Psychologists ; 1983.
43. Beck AT, Steer RA Manual for the Beck Depression Inventory. San Antonio, TX: Psychological Corporation ; 1987.
44. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959 ; 32 (1). 50-55.
45. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 ; 23 (1). 56-62.
46. Kaplan E., Goodglass H., Weintraub S. Boston Naming Test (revised 60-item version). Philadelphia: Lea & Febiger ; 1983.
47. Wechsler D. Wechsler Adult Intelligence Scale and Wechsler Memory Scale Technical Manual. 3rd San Antonio, TX: The Psychological Corporation ; 1997.
48. Trenerry MR, Crosson B., DeBoe J., Leber WR Stroop Neuropsychological Screening Test Manual. Odessa, FL: Psychological Assessment Resources, Inc ; 1989.
49. Army Individual TestBattery AIT. Manual ofdirections andscoring. Washington, DC: War Department, Adjutant General's Office ; 1944.
50. Miller E. Verbal fluency as a function of a measure of verbal intelligence in relation to different types of pathology. Br J Clin Psychol. 1984 ; 23 (1). 53-57. (Pubitemid 14165805)
51. Shohamy D., Myers C., Onalor S., Gluck MA Role of basal ganglia in category learning: how do patients with Parkinson's disease learn ? Behav Neurosci. 2004 ; 118 (4). 676-686. (Pubitemid 38970490)
52. Mohlman J., Hunter-Reel D., Chazin D., et al. A novel approach to treating anxiety and enhancing executive skills in an older adult with Parkinson's disease. Clin Case Stud. 2010 ; 9 (1). 74-90.
53. Deci EL, Koestner R., Ryan RM A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol Bull. 1999 ; 125 (6). 627-668.
54. Abe K., Takanashi M., Yanagihara T. Fatigue in patients with Parkinson's disease. Behav Neurol. 2000 ; 12 (3). 103-106.
55. Frasier LD, Cotrell V., Hooker K. Possible selves and illness: a comparison of individuals with Parkinson's disease, early-stage Alzheimer's disease, and healthy older adults. Int J Behav Dev. 2003 ; 27 (1). 1-11. (Pubitemid 36163720)
56. Zimmerman BJ Self-efficacy: an essential motive to learn. Con-temp Educ Psychol. 2000 ; 25 (1). 82-91.
57. Rose D., Wykes T., Farrier D., Doran AM, Sporle T., Bogner D. What do clients think of cognitive remediation therapy? A consumer-led investigation of satisfaction and side effects. Am J Psychiatr Rehabil. 2008 ; 11 (2). 181-204. (Pubitemid 351507793)